Prosight Management »

Abcellera Biologics shares owned by Prosight Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Prosight Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 2.4M 4.60
2023-06-30 $17M 2.6M 6.46
2023-03-31 $5.7M 754k 7.54
2022-12-31 $3.3M 323k 10.13
2022-09-30 $856k 87k 9.90